Takeda Oncology invites you to participate in this ASH 2022 Lymphoma and Multiple Myeloma Highlights meeting. C-ANPROM/GB/OG/0388 November 2022

TOPICS COVERED

The Takeda Oncology Medical team invites healthcare professionals from the UK and Ireland working in haemato-oncology to two non-promotional ASH 2022 Lymphoma and Multiple Myeloma Highlights meetings. These are taking place on Monday 16^th and Wednesday 18^th January 2023 and Chaired by Prof George Follows and Dr Wendy Osborne, respectively.

At each meeting, an expert panel of speakers will present their selected abstracts from ASH 2022 which will be followed by an interactive discussion and debate with the audience and attendees will have the opportunity to ask questions. Topics will include: multiple myeloma, Hodgkin lymphoma, and high- and low-grade lymphoma.

C-ANPROM/GB/OG/0388 November 2022

WHO SHOULD ATTEND?

Healthcare professionals who specialise in haemato-oncology

C-ANPROM/GB/OG/0388 November 2022

SPEAKERS

• Dr Wendy Osborne (Chair), Freeman Hospital, Newcastle upon Tyne
• Dr Cathy Burton, St James’s University Hospital, Leeds
• Professor Graham Jackson, Freeman Hospital, Newcastle upon Tyne
• Dr Helen Marr, Freeman Hospital, Newcastle upon Tyne
• Dr Tobias Menne, Freeman Hospital, Newcastle upon Tyne

This non-promotional, scientific exchange meeting is organised and fully funded by the medical department of Takeda UK Ltd and is intended for healthcare professionals from the UK and Ireland with a clinical speciality in haemato-oncology only. This meeting may include discussion of both investigational and licensed agents and is in no way intended to promote Takeda products.

C-ANPROM/GB/OG/0388  November 2022